Last reviewed · How we verify
C16G2 Gel
At a glance
| Generic name | C16G2 Gel |
|---|---|
| Also known as | Antimicrobial peptide |
| Sponsor | Armata Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults (PHASE2)
- Study to Evaluate the Safety and Microbiology of C16G2 in Adolescent and Adult Dental Subjects (PHASE2)
- Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects (PHASE2)
- Phase 2, Open-Label Study for Safety, Microbiology and PK of Single or Multiple Oral C16G2 Gel Doses (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |